摘要
目的 :为临床勃起功能障碍 (ED)治疗时海绵体内注射 (ICI)选药提供临床资料。 方法 :5 6例ED病人 ,随机分 2组 ,每组 2 8例。第 1组用酚妥拉明 2～ 10mg +罂粟碱 10～ 3 0mg ,第 2组用酚妥拉明 2～ 5mg +罂粟碱 10～15mg +川芎嗪 40mg注射液治疗。 结果 :第 2组勃起时间、勃起硬度足以完成性交例数均优于第 1组 (P <0 .0 5 )。 结论 :ICI合用川芎嗪可延长勃起时间 ,增强勃起硬度 ,减少海绵体内结节发生 。
Objectives: To supply clinical data for drug selextion in the treatment of erectile dysfunction through intracavernosal injection. Methods: Fifty-six ED patients were randomly classified into 2 groups and received phentolamine along with papaverine(for group 1)or phentolamine, papaverine and ligustrazin hydrochloride(for group 2). Results: Patients in group 2 enjoyed a longer time of erection. More patients in group 2 succeeded in having enough erection time and hardness to complete sexual intercourse (P< 0.05). Conclusions: The extrainjection of ligustrazin hydrochloride injection can help prolong erection duration and hardness and reduce tubercles that might occur in the corpus carvernosal. Therefore it is a safe and inexpensive drug in the intracarvernous injection treatment. Natl J Androl,2003,9(3):200-201
出处
《中华男科学杂志》
CAS
CSCD
2003年第3期200-201,共2页
National Journal of Andrology
关键词
勃起功能障碍
阴茎海绵体内注射
川芎嗪
酚妥拉明
罂粟碱
Erectile dytunction
Intracavenous injection
Ligustrazin hydrochloride
Phentolamine
Papaverine
